HPV: why vaccination is vital

Written by: Professor Chris Nutting
Published:
Edited by: Conor Lynch

Human papillomavirus (HPV) refers to a group of extremely common viruses, and can, in some people, lead to conditions such as genital warts, and, in severe but rare cases, cancer.

 

In one of today’s articles, Professor Chris Nutting, a highly proficient clinical oncologist, explains why it is so important to get the HPV vaccination at an early age, and reveals whether or not there are any related side effects of the vaccination.

What is human papillomavirus (HPV)?

It is a very common illness that affects adults, and most people will actually suffer from it at one stage or another in their lifetime. The reason why it is important is because after many years (sometimes even up to between 20 and 30 years) after infection, a previous HPV infection can predispose the development of a certain cancer. This is why it is so important to try to eradicate this disease through vaccination.

 

What is the HPV vaccination?

The HPV vaccination is mostly given to young adults. It is administered as two doses, usually three to six months apart. This will prevent the individual from contracting the illness in the long run.

 

In many countries, the vaccination is given to all children, normally around the age of 12 or 13. If it is given to children early on in order to greatly reduce the risk of them getting cancer in the long run. 

 

The vaccine works wonders when it comes to reducing the chances of people contracting cancer in later life. The most common cancers that are prevented include head and neck cancer, amongst others.

 

How painful is it?

Fortunately, it is not painful at all, and is normally pinched into either the shoulder or the buttock, and the patient will not suffer from any noticeable pain.

 

Are there any potential side effects?

The HPV vaccine has, fortunately, been very well studied. There are no recognised short-term nor long-term side effects of this particular vaccination.

 

Professor Chris Nutting is a highly qualified and revered London-based clinical oncologist who specialises in head and neck cancer as well as human papillomavirus. Contact him today to book a consultation with him. You can do just that by visiting his Top Doctors profile

By Professor Chris Nutting
Clinical oncology

Professor Christopher Nutting is a prominent consultant clinical oncologist in London whose areas of expertise include head and neck cancer, thyroid cancer, lung cancer and CyberKnife. He is a specialist in radiotherapy and chemotherapy with a particular interest in reducing the side effects of treatment by using highly focussed radiotherapy. 

After graduating from the University of London Professor Nutting went on to take a number of important posts and has become a highly experienced and an extremely well-respected oncologist in London. 

Besides his medical experience, Professor Nutting has impressive teaching credentials, having been appointed Professor in clinical oncology at The Institute of Cancer Research. 

Professor Nutting is keen to offer the best and most up-to-date care for his patients and is at the forefront of his field when it comes to radiotherapy techniques. He is actively involved in research and has contributed to countless peer-reviewed publications. 

View Profile

Overall assessment of their patients


This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.